The FDA has approved three self-administered tests for the high-risk strains of HPV known to cause most cervical cancers.

The U.S. Preventive Services Task Force released new draft guidelines for cervical cancer screening, including recommendations for three screening methods. For the first time, the new recommendations ...

BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market FRANKLIN LAKES, N.J., Jan. 13, 2025 /PRNewswire/ -- BD (Becton, ...

A revolutionary development in cervical cancer screening is transforming the way millions of women approach their health care. The FDA’s recent approval of self-collection kits from leading healthcare ...

The American Cancer Society (ACS) has officially updated its cervical cancer screening guidelines, marking one of the most significant shifts in women’s preventive health in recent years. The revised ...

Since 2024, the U.S. Food and Drug Administration has approved three self-collected HPV tests: Two are done in medical settings using a vaginal swab, and one test can be done at home and mailed to a ...

Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening method for cervical cancer than the method used today. A ...

The American Cancer Society released revised cervical cancer screening guidelines December 4, 2025, introducing self-collection of vaginal samples for HPV testing as an approved option and providing ...

Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...